Responses
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
624 A phase I/II study evaluating the safety and efficacy of a novel long-acting interleukin-7, NT-I7, for patients with newly diagnosed high-grade gliomas after chemoradiotherapy
Compose a Response to This Article
Other responses
No responses have been published for this article.